An open-label adrenal suppression study of hydrocortisone butyrate 0.1% lipocream used three times daily in children 5 to 12 years old with moderate to severe eczema or atopic dermatitis - 21/08/11
Lawrence Eichenfield, MD, Children's Hospital and Health Center of San Diego, San Diego, CA, United States; Charles Ellis, MD, Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States; David Fivenson, MD, David Fivenson M.D. Dermatology PLLC, Ann Arbor, MI, United States; Adelaide Hebert, MD, Houston Medical Center, Houston, TX, United States
Le texte complet de cet article est disponible en PDF. P702 Drs. Eichenfield, Ellis, Fivenson, and Hebert received compensation to perform the clinical research work cited in this poster. Sponsored by an educational grant from Ferndale Laboratories |
Vol 52 - N° 3S
P. P66 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?